Cargando…

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma

The BCL6 (B-Cell Lymphoma 6) gene is a proto-oncogene that is often expressed in diffuse large B-cell lymphomas (DLBCLs). BCL6 loss of function can kill DLBCL cells, demonstrating that BCL6 is necessary for the survival of DLBCL cells and could be a therapeutic target. In this study, we found that B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Qian, Meng, Xiangrui, Liang, Hongwei, Zhang, Huilai, Liu, Xianming, Li, Lanfang, Li, Wei, Sun, Wu, Zhang, Haiyang, Zen, Ke, Zhang, Chen-Yu, Zhou, Zhen, Chen, Xi, Ba, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5205661/ https://www.ncbi.nlm.nih.gov/pubmed/27815824 http://dx.doi.org/10.1007/s13238-016-0316-z

Ejemplares similares

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
por: Wu, Zizheng, et al.
Publicado: (2021)

miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma
por: Wang, Xinyuan, et al.
Publicado: (2020)

Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
por: Meng, Xiangrui, et al.
Publicado: (2018)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Zhang, Tingting, et al.
Publicado: (2020)

Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Zhang, Tingting, et al.
Publicado: (2021)

Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma
por: Chen, Leiyuan, et al.
Publicado: (2020)

Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
por: Qu, Zhenjie, et al.
Publicado: (2022)

miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC
por: Wang, Nan, et al.
Publicado: (2014)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma
por: Li, Jiazheng, et al.
Publicado: (2021)

miR-203 Inhibits Cell Proliferation and Migration of Lung Cancer Cells by Targeting PKCα
por: Wang, Chen, et al.
Publicado: (2013)

Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients
por: Fei, Yue, et al.
Publicado: (2020)

Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma
por: Li, Yang, et al.
Publicado: (2021)

miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
por: Yan, Xin, et al.
Publicado: (2014)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma
por: Zhang, Huilai, et al.
Publicado: (2022)

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells
por: Dong, Ling, et al.
Publicado: (2016)

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
por: Zhang, Haiyang, et al.
Publicado: (2016)

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma
por: Ma, Huixian, et al.
Publicado: (2021)

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1
por: Chen, Xiao-nan, et al.
Publicado: (2014)

Bortezomib enhances the anti-cancer effect of the novel Bruton’s tyrosine kinase inhibitor (BGB-3111) in mantle cell lymphoma expressing BTK
por: Wang, Xianhuo, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
por: Wawire, Jonathan, et al.
Publicado: (2019)

Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells
por: Zhao, Xinying, et al.
Publicado: (2017)

miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6
por: Chen, Jingwen, et al.
Publicado: (2013)

Knockdown of UCA1 restrains cell proliferation and metastasis of diffuse large B-cell lymphoma by counteracting miR-331-3p expression
por: Zhang, Minqing, et al.
Publicado: (2021)

MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer
por: Su, Jiaojiao, et al.
Publicado: (2014)

MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
por: Jin, Fangfang, et al.
Publicado: (2017)

Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway
por: Zhang, Rui, et al.
Publicado: (2022)

miR-342-3p Regulates the Proliferation and Apoptosis of NSCLC Cells by Targeting BCL-2
por: Chen, Zhongjie, et al.
Publicado: (2021)

miR-424-5p regulates apoptosis and cell proliferation via targeting Bcl2 in nucleus pulposus cells
por: Lu, Hua-tuo, et al.
Publicado: (2020)

miR-101 regulates cell proliferation and apoptosis by targeting KDM1A in diffuse large B cell lymphoma
por: Huang, Yiqun, et al.
Publicado: (2019)

Integrated analysis of genome-wide gene expression and DNA methylation microarray of diffuse large B-cell lymphoma with TET mutations
por: Liu, Pengfei, et al.
Publicado: (2017)

The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells
por: Yan, Xin, et al.
Publicado: (2013)

MiR‐34b‐3p represses cell proliferation, cell cycle progression and cell apoptosis in non‐small‐cell lung cancer (NSCLC) by targeting CDK4
por: Feng, Hongxiang, et al.
Publicado: (2019)

MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
por: Yan, Li-Xu, et al.
Publicado: (2014)

Primary cutaneous diffuse large B‐cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
por: Okada, Yosuke, et al.
Publicado: (2021)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
por: Wang, Yanjie, et al.
Publicado: (2023)

Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis
por: Chen, Ling, et al.
Publicado: (2020)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rae08gkrj081tfj4359uion5oc